BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuruvilla SP, Tiruchinapally G, Crouch AC, ElSayed MEH, Greve JM. Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model. PLoS One 2017;12:e0181944. [PMID: 28829785 DOI: 10.1371/journal.pone.0181944] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Gurunathan S, Kang MH, Qasim M, Kim JH. Nanoparticle-Mediated Combination Therapy: Two-in-One Approach for Cancer. Int J Mol Sci 2018;19:E3264. [PMID: 30347840 DOI: 10.3390/ijms19103264] [Cited by in Crossref: 104] [Cited by in F6Publishing: 77] [Article Influence: 26.0] [Reference Citation Analysis]
2 Afrin H, Salazar CJ, Kazi M, Ahamad SR, Alharbi M, Nurunnabi M. Methods of screening, monitoring and management of cardiac toxicity induced by chemotherapeutics. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.01.011] [Reference Citation Analysis]
3 Alemzadeh E, Dehshahri A, Dehghanian AR, Afsharifar A, Behjatnia AA, Izadpanah K, Ahmadi F. Enhanced anti-tumor efficacy and reduced cardiotoxicity of doxorubicin delivered in a novel plant virus nanoparticle. Colloids and Surfaces B: Biointerfaces 2019;174:80-6. [DOI: 10.1016/j.colsurfb.2018.11.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
4 Gonçalves M, Mignani S, Rodrigues J, Tomás H. A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market. Journal of Controlled Release 2020;317:347-74. [DOI: 10.1016/j.jconrel.2019.11.016] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 17.5] [Reference Citation Analysis]
5 Chakraborty E, Sarkar D. Emerging Therapies for Hepatocellular Carcinoma (HCC). Cancers 2022;14:2798. [DOI: 10.3390/cancers14112798] [Reference Citation Analysis]
6 Dos Santos Arruda F, Tomé FD, Miguel MP, de Menezes LB, Nagib PRA, Campos EC, Soave DF, Celes MRN. Doxorubicin-induced Cardiotoxicity and Cardioprotective Agents: Classic and New Players in the Game. Curr Pharm Des 2019;25:109-18. [PMID: 30864503 DOI: 10.2174/1381612825666190312110836] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Das S, Kudale P, Dandekar P, Devarajan PV. Asialoglycoprotein Receptor and Targeting Strategies. In: Devarajan PV, Dandekar P, D'souza AA, editors. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Cham: Springer International Publishing; 2019. pp. 353-81. [DOI: 10.1007/978-3-030-29168-6_12] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
8 Gonçalves M, Mignani S, Rodrigues J, Tomás H. A glance over doxorubicin based-nanotherapeutics: From proof-of-concept studies to solutions in the market. Journal of Controlled Release 2020;317:347-74. [DOI: 10.1016/j.jconrel.2019.11.016] [Reference Citation Analysis]
9 Piktel E, Markiewicz KH, Wilczewska AZ, Daniluk T, Chmielewska S, Niemirowicz-Laskowska K, Mystkowska J, Paprocka P, Savage PB, Bucki R. Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells. Int J Nanomedicine 2020;15:4573-89. [PMID: 32606693 DOI: 10.2147/IJN.S255170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
10 Shaban M, Hasanzadeh M. Biomedical applications of dendritic fibrous nanosilica (DFNS): recent progress and challenges. RSC Adv 2020;10:37116-33. [PMID: 35521236 DOI: 10.1039/d0ra04388e] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
11 Schwach V, Slaats RH, Passier R. Human Pluripotent Stem Cell-Derived Cardiomyocytes for Assessment of Anticancer Drug-Induced Cardiotoxicity. Front Cardiovasc Med 2020;7:50. [PMID: 32322588 DOI: 10.3389/fcvm.2020.00050] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 Chi X, Liu K, Luo X, Yin Z, Lin H, Gao J. Recent advances of nanomedicines for liver cancer therapy. J Mater Chem B 2020;8:3747-71. [DOI: 10.1039/c9tb02871d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
13 Alibolandi M, Hoseini F, Mohammadi M, Ramezani P, Einafshar E, Taghdisi SM, Ramezani M, Abnous K. Curcumin-entrapped MUC-1 aptamer targeted dendrimer-gold hybrid nanostructure as a theranostic system for colon adenocarcinoma. Int J Pharm 2018;549:67-75. [PMID: 30048777 DOI: 10.1016/j.ijpharm.2018.07.052] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
14 Mabrouk AA, Eltablawy NA, El-allawy RM, Abdel Maksoud H, Elsenosi YA. The ameliorating effect of Terminalia muelleri extract on oxidative stress–related factors in induced hepatocellular carcinoma rat model. Gene Reports 2022;26:101482. [DOI: 10.1016/j.genrep.2021.101482] [Reference Citation Analysis]
15 Sharma R, Sharma A, Kambhampati SP, Reddy RR, Zhang Z, Cleland JL, Kannan S, Kannan RM. Scalable synthesis and validation of PAMAM dendrimer-N-acetyl cysteine conjugate for potential translation. Bioeng Transl Med 2018;3:87-101. [PMID: 30065965 DOI: 10.1002/btm2.10094] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
16 Halder J, Pradhan D, Kar B, Ghosh G, Rath G. Nanotherapeutics approaches to overcome P-glycoprotein-mediated multi-drug resistance in cancer. Nanomedicine 2021;:102494. [PMID: 34775061 DOI: 10.1016/j.nano.2021.102494] [Reference Citation Analysis]
17 Smith RJ, Gorman C, Menegatti S. Synthesis, structure, and function of internally functionalized dendrimers. Journal of Polymer Science 2021;59:10-28. [DOI: 10.1002/pol.20200721] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Smith RJ, Gorman CB, Menegatti S. DendriPeps: Expanding Dendrimer Functionality by Hybridizing Poly(amidoamine) (PAMAM) Scaffolds with Peptide Segments. Macromol Rapid Commun 2019;40:1900325. [DOI: 10.1002/marc.201900325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
19 Su X, Zhang X, Liu W, Yang X, An N, Yang F, Sun J, Xing Y, Shang H. Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy. Semin Cancer Biol 2021:S1044-579X(21)00215-7. [PMID: 34375726 DOI: 10.1016/j.semcancer.2021.08.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Saul P, Yang S, Mamone S, Opazo F, Meyer A, Rizzoli SO, Glöggler S. Exotic nuclear spin behavior in dendritic macromolecules. Phys Chem Chem Phys 2021;23:26349-55. [PMID: 34792046 DOI: 10.1039/d1cp04483d] [Reference Citation Analysis]
21 Navya PN, Kaphle A, Srinivas SP, Bhargava SK, Rotello VM, Daima HK. Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano Converg 2019;6:23. [PMID: 31304563 DOI: 10.1186/s40580-019-0193-2] [Cited by in Crossref: 149] [Cited by in F6Publishing: 100] [Article Influence: 49.7] [Reference Citation Analysis]
22 Singh A, Shafi S, Upadhyay T, Najmi AK, Kohli K, Pottoo FH. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment. Curr Top Med Chem 2020;20:1839-54. [PMID: 32579503 DOI: 10.2174/1568026620666200624161801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]